Gene expression analysis reveals GRIN1, SYT1, and SYN2 as significant therapeutic targets and drug repurposing reveals lorazepam and lorediplon as potent inhibitors to manage Alzheimer’s disease

药物重新定位 基因 微阵列分析技术 微阵列 生物 PSEN1型 药品 计算生物学 疾病 遗传学 基因表达 药理学 阿尔茨海默病 医学 早老素 病理
作者
T. Premkumar,Bhavana Katta,Sajitha Lulu,Vino Sundararajan
出处
期刊:Journal of Biomolecular Structure & Dynamics [Taylor & Francis]
卷期号:42 (19): 10352-10373 被引量:3
标识
DOI:10.1080/07391102.2023.2256878
摘要

Alzheimer's disease (AD) is a slowly progressive neurodegenerative disease and a leading cause of dementia. We aim to identify key genes for the development of therapeutic targets and biomarkers for potential treatments for AD. Meta-analysis was performed on six microarray datasets and identified the differentially expressed genes between healthy and Alzheimer's disease samples. Thereafter, we filtered out the common genes which were present in at least four microarray datasets for downstream analysis. We have constructed a gene-gene network for the common genes and identified six hub genes. Furthermore, we investigated the regulatory mechanisms of these hub genes by analysing their interaction with miRNAs and transcription factors. The gene ontology analysis results highlighted the enriched terms significantly associated with hub genes. Through an extensive literature survey, we found that three of the hub genes including GRIN1, SYN2, and SYT1 were critically involved in disease development. To leverage existing drugs for potential repurposing, we predicted drug-gene interaction using the drug-gene interaction database, and performed molecular docking studies. The docking results revealed that the drug compounds had strong interactions and favorable binding with selected hub genes. Lorazepam exhibits a binding energy of -7.3 kcal/mol with GRIN1, Lorediplon exhibits binding energies of -7.7 kcal/mol and -6.3 kcal/mol with the SYT1, and SYN2 respectively. In addition, 100 ns molecular dynamics simulations were carried out for the top complexes and apo protein as well. Furthermore, the MM-PBSA free energy calculations also revealed that these complexes are stable and had favorable energies. According to our study, the identified hub gene could serve as a biomarker as well as a therapeutic target for AD, and the proposed repurposed drug molecules appear to have promising efficacy in treating the disease.Communicated by Ramaswamy H. Sarma.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Hyz发布了新的文献求助10
1秒前
六六发布了新的文献求助10
1秒前
脑洞疼的应助被小迪采纳,获得10
1秒前
超级无敌发布了新的文献求助30
2秒前
2秒前
2秒前
胖虎完成签到,获得积分10
2秒前
科研通AI2S的应助被牧百川采纳,获得10
3秒前
3秒前
3秒前
3秒前
as_eichi发布了新的文献求助30
4秒前
4秒前
xieyangyu发布了新的文献求助10
4秒前
浦肯野发布了新的文献求助10
5秒前
5秒前
minmin完成签到,获得积分10
5秒前
Csy发布了新的文献求助10
5秒前
6秒前
777发布了新的文献求助10
6秒前
7秒前
杨宝仪完成签到,获得积分10
7秒前
7秒前
Nature发布了新的文献求助10
7秒前
Li656943234完成签到,获得积分10
8秒前
8秒前
细心大碗完成签到,获得积分10
8秒前
8秒前
张伟发布了新的文献求助10
8秒前
mlg1552003发布了新的文献求助10
9秒前
陈冠羽发布了新的文献求助10
9秒前
昊儿虫完成签到 ,获得积分10
9秒前
9秒前
10秒前
清爽海云完成签到,获得积分10
10秒前
10秒前
10秒前
KK发布了新的文献求助10
10秒前
dudu发布了新的文献求助10
10秒前
情怀的应助被乘凉采纳,获得10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182977
求助须知:如何正确求助?哪些是违规求助? 9572322
关于积分的说明 21824168
捐赠科研通 7779612
什么是DOI,文献DOI怎么找? 3433774
关于科研通互助平台的介绍 2558024
邀请新用户注册赠送积分活动 2479971